MangoRx launches oral Semaglutide weight-loss treatment 'Slim' at $299/month

MANGOCEUTICALS, INC.

Launched oral Semaglutide ODT compounded with Vitamin B6, branded 'Slim', on MangoRx.com.
Priced at $299 per month; available via MangoRx telemedicine platform with physician review.
Targets global GLP-1 market projected to grow from $49.3B in 2024 to $157.5B by 2035 (Roots Analysis).
CEO Jacob Cohen cites growing GLP-1 demand; product aims to boost revenue and market share.
Oral dissolvable tablet format offers needle-free alternative to traditional injections.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.